Respirator Certification Fees; Public Meeting, 18601-18602 [2013-06850]
Download as PDF
<![CDATA[
18601
Federal Register / Vol. 78, No. 59 / Wednesday, March 27, 2013 / Notices
For Form 2: Antimicrobial
Susceptibility Testing, the annual
frequency of responses per respondent
is 1,452 (121 isolates × 12 months).
Based on previous laboratory
experience, the estimated burden of
completing Form 2 for each
participating laboratory is 1 hour per
response, which includes the time
required for laboratory processing of the
patient’s isolate, gathering and
maintaining the data needed, and
completing and reviewing the collection
of information. For Form 3: Control
Strain Susceptibility Testing, a
‘‘response’’ is defined as the processing
and recording of Regional laboratory
data for a set of seven control strains. It
takes approximately 12 minutes to
process and record the Regional
laboratory data on Form 3 for one set of
seven control strains, of which there are
4 sets. The number of responses per
respondent is 48 (4 sets × 12 months).
There are no additional costs to
respondents.
ESTIMATE OF ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Number of
respondents
Avg. burden
per response
(in hours)
Total annual
burden
(in hours)
Type of respondent
Form name
Clinic ..............................
Laboratory ......................
Demographic Clinical Data Form 1 .....................
Antimicrobial Susceptibility Testing Form 2 ........
Control Strain Susceptibility Testing Form 3 .......
30
5
5
240
1,452
48
11/60
1
12/60
1,320
7,260
48
Total ........................
..............................................................................
40
........................
........................
8,628
Dated: March 21, 2013.
Ron A. Otten,
Director, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
[FR Doc. 2013–07059 Filed 3–26–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on DSK4VPTVN1PROD with NOTICES
Advisory Committee on Breast Cancer
in Young Women (ACBCYW)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Time and Date: 9:00 a.m.–11:00 a.m.
EDT, April 16, 2013.
Place: The meeting will be held via
teleconference.
Teleconference login information is as
follows: For Public:
TOLL–FREE PHONE #: 800–857–4875
Participant passcode: 9377
Net Conference URL: https://
www.mymeetings.com/nc/join/
Conference number: PW8921926
Audience passcode: 9377 or Public
can join the event directly: https://
www.mymeetings.com/nc/
join.php?i=PW8921926&p=9377&t=c
There is also a toll number for anyone
outside of the USA:
TOLL #: 1–212–287–1661
Participant passcode: 9377
Please go to the ACBCYW meeting
Web page to register for this meeting:
https://www.cdc.gov/cancer/breast/
what_cdc_is_doing/conference.htm.
VerDate Mar<15>2010
18:10 Mar 26, 2013
Jkt 229001
Status: Open to the public, limited
only by the number of phone lines
available.
Purpose: The committee provides
advice and guidance to the Secretary,
HHS; the Assistant Secretary for Health;
and the Director, CDC, regarding the
formative research, development,
implementation and evaluation of
evidence-based activities designed to
prevent breast cancer (particularly
among those at heightened risk) and
promote the early detection and support
of young women who develop the
disease. The advice provided by the
Committee will assist in ensuring
scientific quality, timeliness, utility, and
dissemination of credible appropriate
messages and resource materials.
Matters To Be Discussed: The agenda
will include discussions on approaches
to increase awareness of clinicians/
practitioners regarding topics such as
breast health, symptoms, diagnosis, and
treatment of breast cancer in young
women; and information needs and
delivery mechanisms for women at
higher risks for developing breast
cancer. These discussions will be
directed toward the final review and
approval of formal recommendations on
these topics.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Temeika L. Fairley, Ph.D., Designated
Federal Officer, National Center for
Chronic Disease Prevention and Health
Promotion, CDC, 4770 Buford Highway
NE., Mailstop K52, Atlanta, Georgia,
30341, Telephone (770) 488–4518, Fax
(770) 488–4760, Email:
acbcyw@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention, and Agency for Toxic
Substances and Disease Registry.
Dana Redford,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2013–06946 Filed 3–26–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Respirator Certification Fees; Public
Meeting
The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Notice of public meeting.
AGENCY:
SUMMARY: The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC)
announces a public meeting. The
purpose of this meeting is to allow
stakeholders to present information the
impact of an increase on respirator fees
on individual respirator manufacturers,
the respirator market, or on those
industries that rely on NIOSH approved
respiratory equipment.
DATES: April 30, 2013, 10 a.m. to 4 p.m.
EDT, or after the last public commenter
has spoken, whichever occurs first.
ADDRESSES: U.S. Office of Surface
Mining, Three Parkway Center
E:\FR\FM\27MRN1.SGM
27MRN1
18602
Federal Register / Vol. 78, No. 59 / Wednesday, March 27, 2013 / Notices
mstockstill on DSK4VPTVN1PROD with NOTICES
(Greentree), Pittsburgh, PA 15220. This
meeting will also be available by remote
access. Registration information is
available on the NIOSH Web site at
https://www.cdc.gov/niosh.
FOR FURTHER INFORMATION CONTACT:
David Book, NIOSH National Personal
Protective Technology Laboratory
(NPPTL), 626 Cochrans Mill Road,
Pittsburgh, PA 15236 (412) 386–6691 or
(412) 386–5200 (these are not toll free
numbers).
SUPPLEMENTARY INFORMATION:
Public Meeting
NIOSH will hold a public meeting to
allow commenters to present
information on an increase in respirator
certification and approval fees on
individual respirator manufacturers, the
respirator market, or on those industries
that rely on NIOSH approved
respiratory equipment.
Requests to make presentations at the
public meeting should be mailed to the
NIOSH Docket Office, Robert A. Taft
Laboratories, MS–C34, 4676 Columbia
Parkway, Cincinnati, OH 45226.
Requests may also be submitted by
telephone (513) 533–8611, facsimile
(513) 533–8285, or emailed to
nioshdocket@cdc.gov with the words
‘‘respirator fees presentation’’ in the
subject line. All requests to present
should contain the name, address,
telephone number and relevant business
affiliations of the presenter, and the
approximate time requested for the
presentation. Oral presentations will be
limited to 15 minutes. After reviewing
the requests for presentations, NIOSH
will notify the presenter that his/her
presentation is scheduled. If a
participant is not in attendance when
his/her presentation is scheduled to
begin, the remaining participants will be
heard in order. After the last scheduled
speaker is heard, participants who
missed their assigned times may be
allowed to speak, limited by time
available.
Attendees who wish to speak but did
not submit a request for the opportunity
to make a presentation may be given
this opportunity after the scheduled
speakers are heard, at the discretion of
the presiding officer and limited by time
available. This meeting will also be
using audio/LiveMeeting Conferencing,
remote access capabilities where
interested parties may listen in and
view the presentations over the Internet
simultaneously. Parties remotely
accessing the meeting will have the
opportunity to comment during the
open comment period.
Registration is required for both inperson and LiveMeeting participation.
VerDate Mar<15>2010
18:10 Mar 26, 2013
Jkt 229001
Because this meeting is being held at a
Federal site, pre-registration is required
on or before April 26, 2013 and a
government-issued photo ID (driver’s
license or passport) will be required to
obtain entrance to the facility. Non-US
citizens need to register by March 29, to
allow sufficient time for mandatory
facility security clearance procedures to
be completed.
An email confirming registration will
be sent from NIOSH for both in-person
participation and audio conferencing
participation. Details required to
participate via the conferencing will be
provided by NIOSH in a separate email.
This option will be available to
participants on a first come, first served
basis and is limited to the first 100
participants.
Registration information is available
on the NIOSH Web site at https://
www.cdc.gov/niosh.
Dated: March 20, 2013.
John Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
[FR Doc. 2013–06850 Filed 3–26–13; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
receive updates from the Global
Workgroup; State, Tribal, Local and
Territorial Workgroup; the
Communications Workgroup; the Ethics
Subcommittee, and the Health
Disparities Subcommittee, as well as an
update from the CDC Director.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Carmen Villar, M.S.W., Designated
Federal Officer, Advisory Committee to
the Director, CDC, 1600 Clifton Road
NE., M/S D–14, Atlanta, Georgia 30333.
Telephone 404/639–7000, Email:
GHickman@cdc.gov. The deadline for
notification of attendance is April 22,
2013. To register for this meeting, please
send an email to ACDirector@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dana Redford,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention (CDC).
[FR Doc. 2013–06947 Filed 3–26–13; 8:45 am]
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention (CDC)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned committee.
Time and Date: 8:30 a.m.–3:00 p.m.
(EDT), April 25, 2013.
Place: CDC, Building 21, Rooms 1204
A/B, 1600 Clifton Road, NE., Atlanta,
Georgia 30333.
Status: Open to the public, limited
only by the space available. The meeting
room accommodates approximately 50
people. The public is welcome to
participate during the public comment
period, which is tentatively scheduled
from 2:45 p.m. to 2:50 p.m. This
meeting is also available by
teleconference. Please dial (877) 930–
8819 and enter code 1579739.
Purpose: The committee will provide
advice to the CDC Director on strategic
and other broad issues facing CDC.
Matters To Be Discussed: The
Advisory Committee to the Director will
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
[CFDA Number: 93.676]
Announcement of the Award of Fifteen
Single-Source Program Expansion
Supplement Grants to Unaccompanied
Alien Children’s Shelter Care Grantees
Office of Refugee Resettlement,
Administration for Children and
Families, Department of Health and
Human Services.
ACTION: Announcement of the award of
fifteen single-source program expansion
grants to ten current grantees to expand
bed capacity and supportive services to
the increasing number of
unaccompanied alien children.
AGENCY:
SUMMARY: The Administration for
Children and Families (ACF), Office of
Refugee Resettlement (ORR) announces
the award of fifteen single-source
program expansion supplement grants
to the following ten current grantees, for
a total of $47,168,490.
E:\FR\FM\27MRN1.SGM
27MRN1
]]>Agencies
[Federal Register Volume 78, Number 59 (Wednesday, March 27, 2013)]
[Notices]
[Pages 18601-18602]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-06850]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Respirator Certification Fees; Public Meeting
AGENCY: The National Institute for Occupational Safety and Health
(NIOSH) of the Centers for Disease Control and Prevention (CDC),
Department of Health and Human Services (HHS).
ACTION: Notice of public meeting.
-----------------------------------------------------------------------
SUMMARY: The National Institute for Occupational Safety and Health
(NIOSH) of the Centers for Disease Control and Prevention (CDC)
announces a public meeting. The purpose of this meeting is to allow
stakeholders to present information the impact of an increase on
respirator fees on individual respirator manufacturers, the respirator
market, or on those industries that rely on NIOSH approved respiratory
equipment.
DATES: April 30, 2013, 10 a.m. to 4 p.m. EDT, or after the last public
commenter has spoken, whichever occurs first.
ADDRESSES: U.S. Office of Surface Mining, Three Parkway Center
[[Page 18602]]
(Greentree), Pittsburgh, PA 15220. This meeting will also be available
by remote access. Registration information is available on the NIOSH
Web site at https://www.cdc.gov/niosh.
FOR FURTHER INFORMATION CONTACT: David Book, NIOSH National Personal
Protective Technology Laboratory (NPPTL), 626 Cochrans Mill Road,
Pittsburgh, PA 15236 (412) 386-6691 or (412) 386-5200 (these are not
toll free numbers).
SUPPLEMENTARY INFORMATION:
Public Meeting
NIOSH will hold a public meeting to allow commenters to present
information on an increase in respirator certification and approval
fees on individual respirator manufacturers, the respirator market, or
on those industries that rely on NIOSH approved respiratory equipment.
Requests to make presentations at the public meeting should be
mailed to the NIOSH Docket Office, Robert A. Taft Laboratories, MS-C34,
4676 Columbia Parkway, Cincinnati, OH 45226. Requests may also be
submitted by telephone (513) 533-8611, facsimile (513) 533-8285, or
emailed to nioshdocket@cdc.gov with the words ``respirator fees
presentation'' in the subject line. All requests to present should
contain the name, address, telephone number and relevant business
affiliations of the presenter, and the approximate time requested for
the presentation. Oral presentations will be limited to 15 minutes.
After reviewing the requests for presentations, NIOSH will notify the
presenter that his/her presentation is scheduled. If a participant is
not in attendance when his/her presentation is scheduled to begin, the
remaining participants will be heard in order. After the last scheduled
speaker is heard, participants who missed their assigned times may be
allowed to speak, limited by time available.
Attendees who wish to speak but did not submit a request for the
opportunity to make a presentation may be given this opportunity after
the scheduled speakers are heard, at the discretion of the presiding
officer and limited by time available. This meeting will also be using
audio/LiveMeeting Conferencing, remote access capabilities where
interested parties may listen in and view the presentations over the
Internet simultaneously. Parties remotely accessing the meeting will
have the opportunity to comment during the open comment period.
Registration is required for both in-person and LiveMeeting
participation. Because this meeting is being held at a Federal site,
pre-registration is required on or before April 26, 2013 and a
government-issued photo ID (driver's license or passport) will be
required to obtain entrance to the facility. Non[hyphen]US citizens
need to register by March 29, to allow sufficient time for mandatory
facility security clearance procedures to be completed.
An email confirming registration will be sent from NIOSH for both
in-person participation and audio conferencing participation. Details
required to participate via the conferencing will be provided by NIOSH
in a separate email. This option will be available to participants on a
first come, first served basis and is limited to the first 100
participants.
Registration information is available on the NIOSH Web site at
https://www.cdc.gov/niosh.
Dated: March 20, 2013.
John Howard,
Director, National Institute for Occupational Safety and Health,
Centers for Disease Control and Prevention.
[FR Doc. 2013-06850 Filed 3-26-13; 8:45 am]
BILLING CODE 4163-19-P
